陳肇始:暫停接種復必泰疫苗屬預防性措施 未發現安全風險
食衛局局長陳肇始表示,因注意到批號為210102的復必泰疫苗(有效期至2021年6月)藥瓶封蓋有關的包裝瑕疵,故即日起暫停復必泰疫苗接種工作,至另行通知,已預約人士不必前往。
她指,雖然復星指沒有任何理由發現有安全風險,但為安全和謹慎起見,在調查有結果前,都不會接種,形容屬預防性措施。
她又指,存貨中有另一批次210104,為謹慎起見亦會作封存。目前未有已接種上述批次人士數字,稍後衛生署會與復星方面開會跟進。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.